These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33765287)

  • 1. Just the facts: Atrial fibrillation or flutter in patients who are candidates for rate control.
    Scheuermeyer FX; Targonsky E; Stiell I
    CJEM; 2021 Jul; 23(4):437-440. PubMed ID: 33765287
    [No Abstract]   [Full Text] [Related]  

  • 2. Just the facts: atrial fibrillation or flutter in patients who are candidates for rhythm control.
    Stiell IG; Targonsky E; Scheuermeyer F
    CJEM; 2021 Jul; 23(4):441-444. PubMed ID: 33825177
    [No Abstract]   [Full Text] [Related]  

  • 3. [Paroxysmal atrial fibrillation, atrial flutter, and atrial flutter-fibrillation].
    Sumiyoshi M; Nakata Y
    Ryoikibetsu Shokogun Shirizu; 1996; (12):440-3. PubMed ID: 9047505
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter.
    Zaqqa M; Afshar H; Rasekh A; Khoshnevis R; Vaughn WK; Massumi A
    Am J Cardiol; 2000 Jan; 85(1):112-4, A9. PubMed ID: 11078250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECG of the month. Atrial flutter.
    Cunningham SM; Rush JE
    J Am Vet Med Assoc; 2005 Jun; 226(12):1986-8. PubMed ID: 15989179
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
    Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
    Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using ibutilide to convert atrial fibrillation and flutter.
    Sargent DA
    Dimens Crit Care Nurs; 1999; 18(4):2-12. PubMed ID: 10640022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Lewalter T
    J Am Coll Cardiol; 2010 Mar; 55(10):1051-2; author reply 1052-3. PubMed ID: 20202525
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic cardioversion for atrial fibrillation and flutter.
    Cayley WE
    Am Fam Physician; 2005 Dec; 72(11):2217-9. PubMed ID: 16342843
    [No Abstract]   [Full Text] [Related]  

  • 10. Dronedarone is superior to placebo the case for optimism.
    Cooper JA
    J Am Coll Cardiol; 2010 Mar; 55(10):1052; author reply 1052-3. PubMed ID: 20202527
    [No Abstract]   [Full Text] [Related]  

  • 11. Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutter.
    Kayser SR
    Prog Cardiovasc Nurs; 1997; 12(1):39-43. PubMed ID: 9058463
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient Selection Is Critical in Rate or Rhythm Control of Atrial Fibrillation or Flutter.
    Yeh YT; Li AH; Wu YW
    Ann Emerg Med; 2015 Nov; 66(5):562-3. PubMed ID: 26497439
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic conversion of atrial fibrillation and atrial flutter to normal sinus rhythm: the role of ibutilide.
    Katcher MS; Estes NA
    Pharmacotherapy; 1997; 17(1):177-80. PubMed ID: 9017781
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction: acute treatment of atrial fibrillation and flutter--ibutilide in perspective.
    Waldo AL; Pratt CM
    Am J Cardiol; 1996 Oct; 78(8A):1-2. PubMed ID: 8903268
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic pharmacologic therapy for atrial fibrillation and flutter.
    Khouzam S; Kirk M
    Med Health R I; 2004 Apr; 87(4):104-7. PubMed ID: 15168635
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of trans-esophageal cardiac electric stimulation in the evaluation of anti-arrhythmia therapy in patients with paroxysms of atrial fibrillation and atrial flutter].
    Tatarchenko IP; Oleĭnikov VE; Rakhmatullov FK
    Kardiologiia; 1990 Jul; 30(7):98-9. PubMed ID: 2232478
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute treatment of atrial fibrillation and flutter.
    Anderson JL
    Am J Cardiol; 1996 Oct; 78(8A):17-21. PubMed ID: 8903271
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency Department Patients With Atrial Fibrillation or Flutter and an Acute Underlying Medical Illness May Not Benefit From Attempts to Control Rate or Rhythm.
    Scheuermeyer FX; Pourvali R; Rowe BH; Grafstein E; Heslop C; MacPhee J; McGrath L; Ward J; Heilbron B; Christenson J
    Ann Emerg Med; 2015 May; 65(5):511-522.e2. PubMed ID: 25441768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.